Abstract
Endovascular aortic aneurysm repair is widely used for the treatment of abdominal aortic aneurysm (AAA), but has a 10% to 40% incidence of type II endoleak during follow-up. There are various techniques to treat these endoleaks in the case of enlarging of the AAA, but the clinical effectiveness is low. In recent years, preemptive AAA sac embolization has shown some encouraging results with significant AAA shrinkage. However, the presence of embolic material can complicate continued endoleak detection making assessment of treatment outcome difficult. We investigate the ability of contrast-enhanced-ultrasound examination to detect endoleaks in patients undergoing preemptive coil embolization of the AAA sac.
Keywords: Contrast-enhanced ultrasound, Endovascular aneurysm repair, Endoleak, Sac embolization, Coils
Endovascular aortic aneurysm repair (EVAR) is a widely used technique to treat infrarenal abdominal aortic aneurysm (AAA). Even though the technique is associated with low morbidity and mortality, 10% to 40% are complicated by back bleeding from aortic side branches into the residual sac (endoleak type II).1 The majority of the endoleaks resolve spontaneously; however, a small subset do progress leading to sac growth and risk of rupture. Previous studies have shown a potential benefit of preemptive sac embolization, but lack the power and design to be conclusive.2, 3, 4, 5 It is well-known that coils produce artefacts and influence the accuracy of computed tomography angiography (CTA) in follow-up surveillance programs. Contrast-enhanced ultrasound (CEUS) examination might be a valuable option less influenced by coil artefacts.6 In this pilot study, we aimed to describe the capacity of three-dimensional (3D) CEUS for surveillance follow-up and to detect endoleaks after preemptive, perioperative coiling of the aneurysm sac.
Methods
Design study and patients
In October 2022, four consecutive patients scheduled to undergo standard EVAR with infrarenal AAA at the Department of Vascular Surgery, Rigshospitalet, were included in this pilot study. All patients were enrolled after giving informed consent. The patients gave consent for publication of the details and images of their cases.
Endovascular aortic repair
Three patients were treated with GORE Excluder stent graft (W. L. Gore & Associates, Johnson & Johnson, Flagstaff, AZ) and one patient with Cook Zenith Flex stent graft (Cook Medical, Bjaevreskov, Denmark). Preemptive coil embolization of AAA sac during EVAR surgery was performed with a preset number of coils (average, 1.8 m; range, 1.75-1.95 m) independent of the volume and the size of the aneurysm sac, kind of graft, or other morphological and clinical characteristics (Table I, Table II, Table III). The number of coils was extrapolated from the outcomes in a previous randomized controlled trial.4 Each patient underwent the same protocol (Fig 1): a 5F, end-hole (Cordis Corporation, Hialeah, FL) catheter was inserted into the aneurysm sac after completing the release of the main body on the ipsilateral side. The catheter was left in place and the procedure was completed by contralateral limb placement and subsequent balloon molding of the sealing and overlapping regions. The jailed catheter was then used to place coils directly into the sac. Coils were either Nester coils (Cook Medical) or Balt coils (Balt, Montmorency, France) and only a single type of coils was used in each individual patient. After completed embolization, the catheter was removed and the distal attachment site molded again with a molding balloon.
Table I.
Clinical characteristics
Patient | Age | Gender | Smoker | Hypertension | CDK | BMI | Diabetes | Anticoagulant therapy | Antiplatelet ftherapy |
---|---|---|---|---|---|---|---|---|---|
1 | 72 | Male | Y | Y | N | 25 | N | N | N |
2 | 71 | Male | N | Y | Y | 27 | N | Y | N |
3 | 78 | Male | N | N | N | 31 | N | N | Y |
4 | 77 | Male | N | Y | N | 26 | N | N | N |
BMI, Body mass index; CDK, chronic kidney disease.
Table II.
Preoperative data
Patient | Real 3D, mm | Max 3D, mm | CT scan Dmax, cm | GFR |
---|---|---|---|---|
1 | 57.58 | 62.81 | 6.0 | >90 |
2 | - | 87.3 | 8.9 | 57 |
3 | 85.26 | 84.52 | 8.2 | 86 |
4 | 76.47 | 76.18 | 7.8 | 52 |
CT scan Dmax, Maximum diameter in any direction perpendicular to the centerline; Max 3D, maximum diameter in anteroposterior direction perpendicular to the centerline; Real 3D, maximum diameter in any direction perpendicular to the centerline.
Table III.
Operation data
Patient | Type of graft | Coil type | No. of coils | Type of catheter used for coiling | Procedure time, minutes |
---|---|---|---|---|---|
1 | GORE C3 Excluder | Balt pushable 45 mm | 4 | Impress 5F | 126 |
2 | GORE C3 Conformable | Balt pushable with fiber 25 mm | 7 | Impress 5F | 133 |
3 | GORE C3 Conformable | Balt Prestige coil system 65 cm | 3 | Progreat microcatheter | 65 |
4 | Cook Zenith Alpha | Balt pushable with fiber 25 mm | 7 | MPA 6F | 99 |
Fig 1.
Preventive coil embolization of the aneurysm sac during endovascular aortic aneurysm (EVAR) surgery.
Three-dimensional CEUS examination
Each patient underwent a 3D-CEUS scan preoperation and at the 6-month follow-up. All 3D-CEUS scans were performed with an X6-1 xMATRIX array transducer on a Philips EPIQ-7 US system (Philips Medical Systems, Bothell, WA) and patients were examined in supine position. A bolus injection with 2.4 mL of contrast agent (SonoVue, composed of gas microbubbles of sulfur hexafluoride encapsulated by phospholipid shells). All our operators have followed specific training for CEUS examination and are certified internally at our department. The parameters evaluated were presence of leaks, volume of the aneurysm, and the artifacts of coils.7
CTA scans
Contrast-enhanced CTA scans were obtained using a helical 64 slice multiscanner (Toshiba Medical Systems Ltd, Crawley, UK). An 80-mL bolus of nonionic iodinated contrast agent (Iohexol 350 mg/mL, Omni-pague; GE Healthcare Denmark A/S, Copenhagen, DK) was used. Collimation was set to 32 mm, and 3-mm reconstruction in the axial, sagittal, and coronal planes was achieved.
Results
Table I summarizes the clinical characteristics of the patients. At baseline, the 3D-CEUS examination showed the high quality of the images compared with preoperative and postoperative CT scans; the maximum diameter of the aneurysm was similar with both methods in the preoperative period (Table II).
Technical success rate of the sac coiling and EVAR procedure was 100% and no complications occurred in periprocedural or in the follow-up period. The average time to finish EVAR with preemptive embolization was 105 minutes (range, 65-133 minutes). The average additional cost of coiling procedure was approximately 200 euros. Three patients showed no endoleaks at 6 months on either 3D-CEUS examination or CTA. One patient had a type II endoleak that was not evident on baseline duplex US examination or on CT owing to the coil artefacts, but was identified by 3D-CEUS examination (Figs 2 and 3; Table IV). Watchful waiting was undertaken, and it resolved spontaneously by the 1-year follow up.
Fig 2.
Type II endoleak detected by three-dimensional (3D) contrast-enhanced ultrasound (CEUS) examination.
Fig 3.
Coils artifacts influence possibility to detect endoleaks on a computed tomography (CT) scan.
Table IV.
Six months contrast-enhanced ultrasound (CEUS) examination follow-up
Patient | Real 3D, mm | Max 3D, mm | AAA volume, mm2 | Leak | Coils artefacts |
---|---|---|---|---|---|
1 | 63.14 | 63.18 | 132.48 | No | No |
2 | 88.9 | 86.95 | 299.18 | Yes | No |
3 | 79.47 | 78.48 | 244.31 | No | No |
4 | 75.03 | 74.02 | 193.39 | No | No |
AAA, Abdominal aortic aneurysm; CT scan Dmax, maximum diameter in any direction perpendicular to the centerline; Max 3D, maximum diameter in AP-direction perpendicular to the centerline; Real 3D, maximum diameter in any direction perpendicular to the centerline.
Discussion
The 3D-CEUS technique proved to be effective with respect to the objective of our pilot study; we obtained an important result showing a type II endoleak not evident on CT. These results are significant, because they highlight how the quality of 3D-CEUS images can overlap or even surpass, as in the case of coils, the use of CT, and how with a standardized scan it is possible to obtain information of clinical significance. The European Society for Vascular Surgery guidelines recommend CTA at 1 and 12 months after EVAR, and an additional CTA at 6 months in case of type II endoleak or other abnormalities.8 However, the Society for Vascular Surgery guidelines do not exclude duplex US examination, recommending contrast-enhanced CT and color duplex US imaging at 1 month and then at 1 year if no endoleak (CT or duplex US).9 Although many of these leaks are benign, reintervention is performed in approximately 10% of cases, mostly owing to aneurysm sac growth. Even though the technical success of post operative type II endoleak embolization is quite good, clinical success rate of secondary procedures is low (approximately 45%), and some cases require multiple procedures.10 Postoperative embolization also adds exposure to radiation and contrast as well as repeat hospitalizations. For this reason, many studies have been performed to identify risk factors and possible treatments of type II endoleaks.10, 11, 12 Some authors have also used preventive sac embolization using coils or fibrin glue2, 3, 4, 5 with varying success. One of the issues with preventive sac treatment is the difficulty in detecting residual endoleaks during continued follow-up. Indeed, the true effectiveness described in some of these series is questionable because they have relied on CT scans postoperatively. Apart from an article from Natrella et al,2 where CEUS examination was combined with CT, no other studies have used CEUS examination during follow-up, thus potentially underestimating the incidence of type II endoleak owing to the presence of coils artefacts. In designing this pilot study, an easily repeatable and straightforward procedure was created for embolization using a standard number of coils. In our series, if 3D-CEUS examination detected an endoleak that was not seen on the CT scan. The value of CEUS examination in the detection and characterization of endoleaks after EVAR has been demonstrated previously in several studies.4,6,13, 14, 15 Furthermore, other benefits of this method compared with CT scan must be considered, such as the absence of radiation, the use of a contrast medium without side effects and usable in patients with renal failure, and the possibility of using this method bedside for fragile patients.16 CEUS examination is also cost effective compared with CT scan.1 CEUS examination has other potential benefits, such as showing post-EVAR complications and demonstrating that 3D CEUS examination may be more sensitive to endoleak after EVAR than CTA.16, 17, 18
Conclusions
This preliminary experience indicates that CEUS examination can be used in post-EVAR follow-up after sac coil embolization to detect endoleaks. Larger studies are needed to confirm these results.
Disclosures
None.
Footnotes
The editors and reviewers of this article have no relevant financial relationships to disclose per the Journal policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
References
- 1.Faccioli N., Foti G., Casagranda G., Santi E., D'Onofrio M. CEUS versus CT Angiography in the follow-up of abdominal aortic endoprostheses: diagnostic accuracy and activity-based cost analysis. La Radiologia medica. 2018;123:904–909. doi: 10.1007/s11547-018-0926-z. [DOI] [PubMed] [Google Scholar]
- 2.Natrella M., Rapellino A., Navarretta F., et al. Embo-EVAR: a technique to prevent type II endoleak? A single-center experience. Ann Vasc Surg. 2017;44:119–127. doi: 10.1016/j.avsg.2017.01.028. [DOI] [PubMed] [Google Scholar]
- 3.Fabre D., Fadel E., Brenot P., et al. Type II endoleak prevention with coil embolization during endovascular aneurysm repair in high-risk patients. J Vasc Surg. 2015;62:1–7. doi: 10.1016/j.jvs.2015.02.030. [DOI] [PubMed] [Google Scholar]
- 4.Fabre D., Mougin J., Mitilian D., et al. Prospective, randomised two centre trial of endovascular repair of abdominal aortic aneurysm with or without sac Embolisation. Eur J Vasc Endovasc Surg. 2021;61:201–209. doi: 10.1016/j.ejvs.2020.11.028. [DOI] [PubMed] [Google Scholar]
- 5.Piazza M., Frigatti P., Scrivere P., et al. Role of aneurysm sac embolization during endovascular aneurysm repair in the prevention of type II endoleak-related complications. J Vasc Surg. 2013;57:934–941. doi: 10.1016/j.jvs.2012.10.078. [DOI] [PubMed] [Google Scholar]
- 6.Abbas A., Hansrani V., Sedgwick N., Ghosh J., McCollum C.N. 3D contrast enhanced ultrasound for detecting endoleak following endovascular aneurysm repair (EVAR) Eur J Vasc Endovasc Surg. 2014;47:487–492. doi: 10.1016/j.ejvs.2014.02.002. [DOI] [PubMed] [Google Scholar]
- 7.Bredahl K.K., Taudorf M., Lönn L., Vogt K.C., Sillesen H., Eiberg J.P. Contrast enhanced ultrasound can replace computed tomography angiography for surveillance after endovascular aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2016;52:729–734. doi: 10.1016/j.ejvs.2016.07.007. [DOI] [PubMed] [Google Scholar]
- 8.Wanhainen A., Van Herzeele I., Bastos Goncalves F., et al. Editor's choice -- European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg. 2024;67:192–331. doi: 10.1016/j.ejvs.2023.11.002. [DOI] [PubMed] [Google Scholar]
- 9.Chaikof E.L., Dalman R.L., Eskandari M.K., et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67:2–77.e2. doi: 10.1016/j.jvs.2017.10.044. [DOI] [PubMed] [Google Scholar]
- 10.Piazza M., Squizzato F., Miccoli T., et al. Definition of type II endoleak risk based on preoperative anatomical characteristics. J Endovasc Ther. 2017;24:566–572. doi: 10.1177/1526602817712511. [DOI] [PubMed] [Google Scholar]
- 11.Couchet G., Pereira B., Carrieres C., et al. Predictive factors for type II endoleaks after treatment of abdominal aortic aneurysm by conventional endovascular aneurysm repair. Ann Vasc Surg. 2015;29:1673–1679. doi: 10.1016/j.avsg.2015.07.007. [DOI] [PubMed] [Google Scholar]
- 12.Sampaio S.M., Panneton J.M., Mozes G.I., et al. Aneurysm sac thrombus load predicts type II endoleaks after endovascular aneurysm repair. Ann Vasc Surg. 2005;19:302–309. doi: 10.1007/s10016-005-0002-8. [DOI] [PubMed] [Google Scholar]
- 13.Pfister K., Schierling W., Jung E.M., Apfelbeck H., Hennersperger C., Kasprzak P.M. Standardized 2D ultrasound versus 3D/4D ultrasound and image fusion for measurement of aortic aneurysm diameter in follow-up after EVAR. Clin Hemorheol Microcirc. 2016;62:249–260. doi: 10.3233/CH-152012. [DOI] [PubMed] [Google Scholar]
- 14.Clevert D.A., Minaifar N., Kopp R., et al. Imaging of endoleaks after endovascular aneurysm repair (EVAR) with contrast-enhanced ultrasound (CEUS). A pictorial comparison with CTA. Clin Hemorheol Microcirc. 2009;41:151–168. doi: 10.3233/CH-2009-1160. [DOI] [PubMed] [Google Scholar]
- 15.Low G., Winters S.D., Owen R.J. Surveillance of a coiled renal artery aneurysm by contrast-enhanced ultrasound with definity. J Vasc Surg. 2011;54:1801–1804. doi: 10.1016/j.jvs.2011.06.077. [DOI] [PubMed] [Google Scholar]
- 16.Bredahl K., Sandholt B., Lönn L., et al. Three-dimensional ultrasound evaluation of small asymptomatic abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2015;49:289–296. doi: 10.1016/j.ejvs.2014.12.022. [DOI] [PubMed] [Google Scholar]
- 17.Faustino C.B., Ventura C., Portugal M.F.C., Brunheroto A., Teivelis M.P., Wolosker N. Initial experience with duplex scan combined with contrast-enhanced ultrasound for follow-up of endovascular abdominal aortic aneurysm repair. Jornal vascular brasileiro. 2021;20 doi: 10.1590/1677-5449.200093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lowe C., Abbas A., Rogers S., Smith L., Ghosh J., McCollum C. Three-dimensional contrast-enhanced ultrasound improves endoleak detection and classification after endovascular aneurysm repair. J Vasc Surg. 2017;65:1453–1459. doi: 10.1016/j.jvs.2016.10.082. [DOI] [PubMed] [Google Scholar]